Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sofosbuvir (sovaldi) (1 trial)
velpatasvir (Epclusa) (1 trial)
voxilaprevir (Vosevi) (1 trial)
Hepatitis (Phase 2)
Hepatitis C (Phase 2)
Hepatitis C, Chronic (Phase 2)
Trials (1 total)
Trial APIs (3 total)